Industrial Policy Memo
This summer, National Economic Council Director Brian Deese articulated a new vision for a robust and equitable U.S. industrial policy. The strategy seeks to help us reach the full potential of American competitiveness while delivering justice, equity, and prosperity to all citizens.
To inform the Administration’s new strategy, we pulled together a curated set of ideas from our extensive portfolio of nonpartisan, actionable ideas in science and technology policy. These ideas were diversely sourced from more than 300 Day One contributors — including students, academics, activists, industry leaders, local and international government officials, and more.
Our letter addresses each of the industrial strategy’s core pillars:
Pillar I: Supply-Chain Resilience
Pillar II: Targeted Public Investment
Pillar III: Public Procurement
Pillar IV: Climate Resilience
Pillar V: Equity
We hope that these ideas help advance the vision of a modern industrial policy that benefits all Americans.
By providing essential funding mechanisms, the Bioeconomy Finance Program will reduce the risks inherent in biotechnology innovation, encouraging more private sector investment.
While the U.S. has made significant advancements and remained a global leader in biotechnology over the past decade, the next four years will be critical in determining whether it can sustain that leadership.
It’s paramount to balance both innovation capabilities and risk as we work towards ensuring that the U.S. bioeconomy is a priority area for both the Nation and for National Security.
The Federation of American Scientists supports the National Security Commission on Emerging Biotechnology’s Final Report and the Recommendations contained within it.